153 related articles for article (PubMed ID: 38126438)
1. DEVELOPMENT OF ADENOCARCINOMA AFTER RADIOFREQUENCY ABLATION OF BARRETT'S ESOPHAGUS ASSOCIATED TO FUNDOPLICATION AND SUPPRESSION-DUODENAL DIVERSION PROCEDURE: A LESSON TO BE LEARNED.
Braghetto I
Arq Bras Cir Dig; 2023; 36():e1786. PubMed ID: 38126438
[TBL] [Abstract][Full Text] [Related]
2. Effects of Nissen fundoplication on endoscopic endoluminal radiofrequency ablation of Barrett's esophagus.
O'Connell K; Velanovich V
Surg Endosc; 2011 Mar; 25(3):830-4. PubMed ID: 20676687
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
[TBL] [Abstract][Full Text] [Related]
4. Management of Barrett's esophagus with dysplasia refractory to radiofrequency ablation.
Raphael KL; Trindade AJ
World J Gastroenterol; 2020 May; 26(17):2030-2039. PubMed ID: 32536772
[TBL] [Abstract][Full Text] [Related]
5. Surgical Management of Barrett's Esophagus.
Peyre CG; Watson TJ
Gastroenterol Clin North Am; 2015 Jun; 44(2):459-71. PubMed ID: 26021205
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic Treatment of Early Barrett's Neoplasia: Expanding Indications, New Challenges.
Pech O
Adv Exp Med Biol; 2016; 908():99-109. PubMed ID: 27573769
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett's esophagus.
Lee JK; Cameron RG; Binmoeller KF; Shah JN; Shergill A; Garcia-Kennedy R; Bhat YM
Endoscopy; 2013 Jul; 45(7):571-4. PubMed ID: 23592390
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic eradication therapy for mucosal neoplasia in Barrett's esophagus.
Dunbar KB
Curr Opin Gastroenterol; 2013 Jul; 29(4):446-53. PubMed ID: 23703368
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic therapy of esophageal premalignancy and early malignancy.
Nealis TB; Washington K; Keswani RN
J Natl Compr Canc Netw; 2011 Aug; 9(8):890-9. PubMed ID: 21900219
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
[TBL] [Abstract][Full Text] [Related]
11. Long-term durability of radiofrequency ablation for Barrett's-related neoplasia.
Haidry R; Lovat L
Curr Opin Gastroenterol; 2015 Jul; 31(4):316-20. PubMed ID: 26039723
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic ablation of Barrett's neoplasia with a new focal radiofrequency device: initial experience with the Halo60.
Allen B; Kapoor N; Willert R; McEwan H; Fullarton G; Penman I
Endoscopy; 2012 Jul; 44(7):707-10. PubMed ID: 22723187
[TBL] [Abstract][Full Text] [Related]
13. Management of Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma.
Cotton CC; Eluri S; Shaheen NJ
Gastroenterol Clin North Am; 2022 Sep; 51(3):485-500. PubMed ID: 36153106
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors of radiofrequency ablation failure in the treatment of dysplastic Barrett's esophagus.
Weiss S; Pellat A; Corre F; Abou Ali E; Belle A; Terris B; Leconte M; Dohan A; Chaussade S; Coriat R; Barret M
Clin Res Hepatol Gastroenterol; 2023 Jan; 47(1):102065. PubMed ID: 36494071
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic laser ablation of nondysplastic Barrett's epithelium: is it worthwhile?
Bonavina L; Ceriani C; Carazzone A; Segalin A; Ferrero S; Peracchia A
J Gastrointest Surg; 1999; 3(2):194-9. PubMed ID: 10457346
[TBL] [Abstract][Full Text] [Related]
16. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus: initial results and lessons learned.
Velanovich V
Surg Endosc; 2009 Oct; 23(10):2175-80. PubMed ID: 19263139
[TBL] [Abstract][Full Text] [Related]
18. Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy.
Odze RD; Lauwers GY
Endoscopy; 2008 Dec; 40(12):1008-15. PubMed ID: 19065484
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
[TBL] [Abstract][Full Text] [Related]
20. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
